Axogen, Inc. 8-K

What Happened
Axogen, Inc. (AXGN) filed Form 8-K on February 24, 2026 to report its fourth quarter 2025 financial results. The company furnished a press release (Exhibit 99.1) and a financial results presentation (Exhibit 99.2) with the filing. The presentation may be used in discussions with analysts, investors, and others and is available via the company’s news/events page.

Key Details

• Form 8-K filed on February 24, 2026 reporting Q4 2025 results (Item 2.02 Results of Operations and Financial Condition).
• Press release furnished as Exhibit 99.1 and financial results presentation furnished as Exhibit 99.2 (Item 9.01).
• Company noted the presentation may be used in communications with analysts, investors and posted at axogeninc.com/news-events (Item 7.01, Regulation FD disclosure).
• The filing is signed by Marc Began, Executive Vice President, General Counsel and Chief Compliance Officer.

Why It Matters
This 8-K is a routine investor disclosure that makes Axogen’s latest quarterly earnings and revenue information broadly available and compliant with Regulation FD. Investors should review the furnished press release and presentation for the company’s reported revenue, earnings, and any management commentary to assess impacts on outlook and valuation.